Recent advances in tyrosine kinase inhibitors

被引：40
|
作者：
Fry, DW
机构：
[1] Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company Ann, Arbor
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31 | 1996年 / 31卷
关键词：
D O I：
10.1016/S0065-7743(08)60455-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：151 / 160
页数：10
相关论文
共 50 条
  • [21] Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma
    Sobczuk, Pawel
    Cholewinski, Michal
    Rutkowski, Piotr
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (05) : 501 - 510
  • [22] Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors
    Hoi, Pui Man
    Li, Shang
    Vong, Chi Teng
    Tseng, Hisa Hui Ling
    Kwan, Yiu Wa
    Lee, Simon Ming-Yuen
    [J]. METHODS, 2015, 71 : 85 - 91
  • [23] Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances
    Bryan, Marian C.
    Rajapaksa, Naomi S.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (20) : 9030 - 9058
  • [24] Recent advances in the research and development of RAF kinase inhibitors
    Smith, Roger A.
    Dumas, Jacques
    Adnane, Lila
    Wilhelm, Scott A.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1071 - 1089
  • [25] Recent Advances in the Development of Multi-Kinase Inhibitors
    Krug, Martin
    Hilgeroth, Andreas
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1312 - 1327
  • [26] Recent Advances in the Development of Casein Kinase 1 Inhibitors
    Li, Sha-Sha
    Dong, Yue-Hui
    Liu, Zhao-Peng
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (08) : 1585 - 1604
  • [27] Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
    Fleuren, Emmy D. G.
    Vlenterie, Myrella
    van der Graaf, Winette T. A.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer Agents
    Azimian, Fereshteh
    Dastmalchi, Siavoush
    [J]. CURRENT MEDICINAL CHEMISTRY, 2023, 30 (24) : 2734 - 2761
  • [29] Recent advances in Bcr-Abl tyrosine kinase inhibitors for overriding T315I mutation
    Liu, Juan
    Zhang, Yuan
    Huang, Honglin
    Lei, Xiaoyong
    Tang, Guotao
    Cao, Xuan
    Peng, Junmei
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (03) : 649 - 664
  • [30] Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis
    Liu, Qi
    Xia, Yuan
    Liu, Lin
    Zhou, Yuan
    Li, Yumei
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
12345